[144] Itron Inc SEC Filing
Form 144 notice for Itron, Inc. (ITRI) shows a proposed sale of 1,786 common shares held at Fidelity Brokerage Services with an aggregate market value of $223,798.48, with an approximate sale date of 08/25/2025 on NASDAQ. The shares were acquired on 08/22/2025 through restricted stock vesting and the payment nature is listed as compensation. The filing also discloses prior sales by the same person in the past three months: 1,729 shares sold on 05/27/2025 for $198,740.08 and 35,461 shares sold on 06/04/2025 for $4,245,142.69. The notice includes the standard signature representation that the seller is not aware of undisclosed material adverse information.
- Transaction disclosed as restricted stock vesting, indicating the sale stems from compensation rather than unknown sources
- Filing lists broker and planned market (Fidelity Brokerage Services LLC on NASDAQ), providing execution transparency
- Substantial prior sale of 35,461 shares on 06/04/2025 for $4,245,142.69 represents notable insider liquidity in the recent quarter
Insights
TL;DR Insider intends to sell recently vested shares; recent large disposals were executed in May and June.
The filing documents a routine Rule 144 notice for a 1,786-share sale tied to restricted stock vesting, with proceeds estimated at $223,798.48. Material prior dispositions include a 35,461-share sale in June generating $4.245M. For investors, Form 144s signal insider liquidity but do not alone indicate company performance. The data is factual and limited to transaction details; there is no forward-looking guidance or financial results disclosed here.
TL;DR The filing is a compliance disclosure of insider sales following vesting, with standard attestations about material information.
This Form 144 appears procedural: it records sale logistics, broker, and acquisition source (restricted stock vesting). The seller affirmed no undisclosed material adverse information. From a governance standpoint, the filing meets disclosure obligations; it does not provide context on reasons for sales beyond compensation vesting or indicate any regulatory or governance issues.